Full Text (PDF)
Review Article

Vaccine Safety in Pregnancy

Priyanka Thakur, Vishal Gaur, Abhishek Pal

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Trauma and Emergency Pediatrics 14(2):p 53-54, APRIL-JUNE 2022. | DOI: https://doi.org/10.21088/ijtep.2348.9987.14222.6

How Cite This Article:

Vishal Gaur, Abhishek Pal, Priyanka Thakur/Vaccine Safety in Pregnancy/Indian J Trauma Emerg Pediatr.2022;14(2):53–54.

Timeline

Received : April 29, 2022         Accepted : June 03, 2022          Published : June 30, 2022

Abstract

Immunize dubious infectious disease are accountable for significant maternal, neonatal and young infant despair and loss of life. While there is emerging confirmation as well as theoretical thought indicating that certain. Vaccine Sarerisk free for pregnant women and fetuses, policy– formulation is difficult because of behold potential danger to the fetus. The immature adaptive immune system of neonate impulsive infant build them particularly vulnerable despair and loss of life due to infection. Vaccinated pregnant women can defend the fetus. It can also directly defend the fetus via specific transplant from the mother in time of pregnancy.


References

  • 1.   Demicheli V, Barale A, Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Review, 2008; http://apps.who.int/rhl/reviews/CD002959.pdf .
  • 2.   World Health Organization (WHO). Tetanus vaccine: WHO position paper, Weekly Epidemiological Record.
  • 3.   Robert W. Sears, MD, FAAP. The vaccine book : making the right decision for your child
  • 4.   ElkeLeuridan, Marta Nunes, Chrissie Jones. Maternal Immunization 1st Edition-26 November, 2019

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Vishal Gaur, Abhishek Pal, Priyanka Thakur/Vaccine Safety in Pregnancy/Indian J Trauma Emerg Pediatr.2022;14(2):53–54.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
April 29, 2022 June 03, 2022 June 30, 2022

DOI: https://doi.org/10.21088/ijtep.2348.9987.14222.6

Keywords

TheoreticalPolicy-formulationVulnerableTransplant

Article Level Metrics

Last Updated

Monday 27 July 2026, 07:44:39 (IST)


1085

Accesses

1
184
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received April 29, 2022
Accepted June 03, 2022
Published June 30, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share